Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans

The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitoch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human molecular genetics Jg. 26; H. 15; S. 2864
Hauptverfasser: Hayashi, Genki, Jasoliya, Mittal, Sahdeo, Sunil, Saccà, Francesco, Pane, Chiara, Filla, Alessandro, Marsili, Angela, Puorro, Giorgia, Lanzillo, Roberta, Brescia Morra, Vincenzo, Cortopassi, Gino
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 01.08.2017
Schlagworte:
ISSN:1460-2083, 1460-2083
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitochondrial gene expression is more dependent on DMF's target Nrf2 than hydroxycarboxylic acid receptor 2 (HCAR2). Thus, DMF induces mitochondrial biogenesis primarily through its action on Nrf2, and is the first drug demonstrated to increase mitochondrial biogenesis with in vivo human dosing. This is the first demonstration that mitochondrial biogenesis is deficient in Multiple Sclerosis patients, which could have implications for MS pathophysiology and therapy. The observation that DMF stimulates mitochondrial biogenesis, gene expression and function suggests that it could be considered for mitochondrial disease therapy and/or therapy in muscle disease in which mitochondrial function is important.
AbstractList The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitochondrial gene expression is more dependent on DMF's target Nrf2 than hydroxycarboxylic acid receptor 2 (HCAR2). Thus, DMF induces mitochondrial biogenesis primarily through its action on Nrf2, and is the first drug demonstrated to increase mitochondrial biogenesis with in vivo human dosing. This is the first demonstration that mitochondrial biogenesis is deficient in Multiple Sclerosis patients, which could have implications for MS pathophysiology and therapy. The observation that DMF stimulates mitochondrial biogenesis, gene expression and function suggests that it could be considered for mitochondrial disease therapy and/or therapy in muscle disease in which mitochondrial function is important.The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitochondrial gene expression is more dependent on DMF's target Nrf2 than hydroxycarboxylic acid receptor 2 (HCAR2). Thus, DMF induces mitochondrial biogenesis primarily through its action on Nrf2, and is the first drug demonstrated to increase mitochondrial biogenesis with in vivo human dosing. This is the first demonstration that mitochondrial biogenesis is deficient in Multiple Sclerosis patients, which could have implications for MS pathophysiology and therapy. The observation that DMF stimulates mitochondrial biogenesis, gene expression and function suggests that it could be considered for mitochondrial disease therapy and/or therapy in muscle disease in which mitochondrial function is important.
The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans. The induction of mitochondrial gene expression is more dependent on DMF's target Nrf2 than hydroxycarboxylic acid receptor 2 (HCAR2). Thus, DMF induces mitochondrial biogenesis primarily through its action on Nrf2, and is the first drug demonstrated to increase mitochondrial biogenesis with in vivo human dosing. This is the first demonstration that mitochondrial biogenesis is deficient in Multiple Sclerosis patients, which could have implications for MS pathophysiology and therapy. The observation that DMF stimulates mitochondrial biogenesis, gene expression and function suggests that it could be considered for mitochondrial disease therapy and/or therapy in muscle disease in which mitochondrial function is important.
Author Filla, Alessandro
Lanzillo, Roberta
Saccà, Francesco
Jasoliya, Mittal
Brescia Morra, Vincenzo
Hayashi, Genki
Cortopassi, Gino
Marsili, Angela
Puorro, Giorgia
Sahdeo, Sunil
Pane, Chiara
Author_xml – sequence: 1
  givenname: Genki
  surname: Hayashi
  fullname: Hayashi, Genki
  organization: Department of Molecular Biosciences, University of California, Davis, 95616 CA, USA
– sequence: 2
  givenname: Mittal
  surname: Jasoliya
  fullname: Jasoliya, Mittal
  organization: Department of Molecular Biosciences, University of California, Davis, 95616 CA, USA
– sequence: 3
  givenname: Sunil
  surname: Sahdeo
  fullname: Sahdeo, Sunil
  organization: Janssen Pharmaceuticals, 3210 Merryfield Row, San Diego, 92121 CA, USA
– sequence: 4
  givenname: Francesco
  surname: Saccà
  fullname: Saccà, Francesco
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 5
  givenname: Chiara
  surname: Pane
  fullname: Pane, Chiara
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 6
  givenname: Alessandro
  surname: Filla
  fullname: Filla, Alessandro
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 7
  givenname: Angela
  surname: Marsili
  fullname: Marsili, Angela
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 8
  givenname: Giorgia
  surname: Puorro
  fullname: Puorro, Giorgia
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 9
  givenname: Roberta
  surname: Lanzillo
  fullname: Lanzillo, Roberta
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 10
  givenname: Vincenzo
  surname: Brescia Morra
  fullname: Brescia Morra, Vincenzo
  organization: Department of Neurosciences, Odontostomatological and Reproductive Sciences, University Federico II, Naples 80131, Italy
– sequence: 11
  givenname: Gino
  surname: Cortopassi
  fullname: Cortopassi, Gino
  organization: Department of Molecular Biosciences, University of California, Davis, 95616 CA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28460056$$D View this record in MEDLINE/PubMed
BookMark eNpNUEtLxDAYDLLiPvTiD5AcvdTNo3n0KOsTFr2455ImX7eRNl2bFtx_b8AVPM0wMwzMLNEs9AEQuqbkjpKCr5tuv3bum0p1hhY0lyRjRPPZPz5Hyxg_CaEy5-oCzZlODhFygXYPvoOxOba4njozmBFwB84njPhtqFnm4ADBQRhx58feNn1wgzctrny_hwDRR-xD8ixgExxuUkuIl-i8Nm2EqxOu0O7p8WPzkm3fn18399vMcqXHzApRMUeogFobwoXh3NpCscIy45xMmpY5IUC4qq0xwhkilRaKU66dK2q2Qre_vYeh_5ogjmXno4W2NQH6KZZUF7mgmimdojen6FSlheVh8Gnvsfy7gv0AcbhiXw
CitedBy_id crossref_primary_10_3389_fcell_2025_1604320
crossref_primary_10_1016_j_lfs_2019_116863
crossref_primary_10_1016_j_mcn_2019_103413
crossref_primary_10_3390_ijms20030719
crossref_primary_10_1111_apha_13590
crossref_primary_10_1186_s13601_020_00362_7
crossref_primary_10_1073_pnas_2319782121
crossref_primary_10_3389_fphar_2024_1437939
crossref_primary_10_3390_antiox11061146
crossref_primary_10_1007_s10565_024_09969_z
crossref_primary_10_3390_antiox13030303
crossref_primary_10_1155_2021_9577874
crossref_primary_10_1016_j_phymed_2023_154698
crossref_primary_10_1016_j_taap_2018_09_014
crossref_primary_10_3390_antiox12030740
crossref_primary_10_1016_j_gendis_2025_101645
crossref_primary_10_26508_lsa_201900563
crossref_primary_10_3389_fgene_2019_00435
crossref_primary_10_1007_s11910_018_0829_3
crossref_primary_10_1016_j_exger_2019_110767
crossref_primary_10_3390_ph13100306
crossref_primary_10_1080_14737175_2024_2376840
crossref_primary_10_1155_2019_8592348
crossref_primary_10_1161_CIRCULATIONAHA_119_043578
crossref_primary_10_1093_hmg_ddaa282
crossref_primary_10_3389_fnins_2023_1260977
crossref_primary_10_3892_etm_2021_10730
crossref_primary_10_1016_j_mito_2022_11_003
crossref_primary_10_1038_s41598_024_64317_9
crossref_primary_10_3390_antiox10091491
crossref_primary_10_1016_j_mcn_2018_09_002
crossref_primary_10_1007_s10735_025_10563_8
crossref_primary_10_1016_j_taap_2022_116167
crossref_primary_10_1093_eurjpc_zwaa134
crossref_primary_10_3390_antiox12111928
crossref_primary_10_3390_biomedicines10082043
crossref_primary_10_1080_14737175_2017_1356721
crossref_primary_10_1186_s12929_023_00975_7
crossref_primary_10_1080_03008207_2022_2089565
crossref_primary_10_1038_s41582_025_01065_y
crossref_primary_10_1042_BCJ20200331
crossref_primary_10_3390_biology11081132
crossref_primary_10_1016_j_expneurol_2020_113247
crossref_primary_10_1016_j_phymed_2025_156851
crossref_primary_10_1016_j_fochms_2024_100234
crossref_primary_10_1177_17448069221124920
crossref_primary_10_1371_journal_pone_0278111
crossref_primary_10_1038_s41582_022_00634_9
crossref_primary_10_1007_s12640_024_00694_3
crossref_primary_10_1016_j_jep_2023_117638
crossref_primary_10_1016_j_bbadis_2019_165575
crossref_primary_10_1093_toxres_tfab073
crossref_primary_10_3389_fnins_2022_814445
crossref_primary_10_1016_j_intimp_2022_108867
crossref_primary_10_1016_j_bcp_2025_117278
crossref_primary_10_3390_antiox11071389
crossref_primary_10_1038_s41582_023_00839_6
crossref_primary_10_1038_s41586_023_05720_6
crossref_primary_10_1016_j_freeradbiomed_2022_08_012
crossref_primary_10_3390_ijms25063334
crossref_primary_10_1016_j_cmet_2021_03_003
crossref_primary_10_1016_j_freeradbiomed_2021_12_001
crossref_primary_10_1177_17562864241306565
crossref_primary_10_1177_1759091419899782
crossref_primary_10_3389_fphar_2021_612981
crossref_primary_10_1016_j_neuint_2022_105380
crossref_primary_10_1021_acschembio_4c00617
crossref_primary_10_1016_j_freeradbiomed_2021_12_008
crossref_primary_10_1242_dmm_052128
crossref_primary_10_1177_1179069518766524
crossref_primary_10_1007_s11357_023_01011_0
crossref_primary_10_3390_cells11152401
crossref_primary_10_17816_ACEN_1219
crossref_primary_10_3390_biomedicines9091196
crossref_primary_10_1016_j_ijbiomac_2018_11_190
crossref_primary_10_15252_emmm_201708604
crossref_primary_10_1111_jnc_16171
crossref_primary_10_1074_jbc_REV119_007624
crossref_primary_10_1016_j_bbr_2025_115805
crossref_primary_10_3390_ijms22136913
crossref_primary_10_1007_s12031_018_1159_2
crossref_primary_10_1007_s13311_019_00764_x
crossref_primary_10_1161_JAHA_124_038505
crossref_primary_10_3390_ijms18102173
crossref_primary_10_1186_s13023_021_01758_9
crossref_primary_10_1242_dmm_030502
crossref_primary_10_15252_emmm_201911589
crossref_primary_10_1016_j_jsbmb_2018_11_017
crossref_primary_10_3390_ijms222111806
crossref_primary_10_3389_fphar_2019_01099
crossref_primary_10_1007_s43440_020_00076_4
crossref_primary_10_3390_toxics11040393
crossref_primary_10_3390_antiox11010026
crossref_primary_10_1016_j_ibneur_2022_11_001
crossref_primary_10_1016_j_biopha_2020_111058
crossref_primary_10_1016_j_freeradbiomed_2022_07_013
crossref_primary_10_1371_journal_pone_0217776
crossref_primary_10_1016_j_intimp_2025_115267
crossref_primary_10_2174_0113816128288707240404051856
crossref_primary_10_3390_ijms252312637
crossref_primary_10_1080_00207454_2023_2295227
crossref_primary_10_3390_antiox10071069
ContentType Journal Article
Copyright The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/hmg/ddx167
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1460-2083
ExternalDocumentID 28460056
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P01 AG025532
– fundername: NIGMS NIH HHS
  grantid: T32 GM099608
– fundername: NEI NIH HHS
  grantid: R01 EY012245
– fundername: NINDS NIH HHS
  grantid: R01 NS077777
GroupedDBID ---
-DZ
-E4
.2P
.I3
.XZ
.ZR
0R~
18M
1TH
29I
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFYAG
AGINJ
AGKEF
AGQXC
AGSYK
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
AJNCP
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ARIXL
ATGXG
AXUDD
AYOIW
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
EBS
ECM
EE~
EIF
EJD
EMOBN
F5P
F9B
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
NU-
NVLIB
O9-
OAWHX
OBC
OBOKY
OBS
OCZFY
ODMLO
OEB
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SJN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
XSW
YAYTL
YKOAZ
YXANX
ZKX
~91
7X8
AJBYB
ID FETCH-LOGICAL-c378t-c55b2d015ef8a035a33cc9729c2add68a086400e037fcaa5da0678573138dd9f2
IEDL.DBID 7X8
ISICitedReferencesCount 108
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000405706800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1460-2083
IngestDate Thu Oct 02 12:00:40 EDT 2025
Thu Apr 03 06:52:19 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c378t-c55b2d015ef8a035a33cc9729c2add68a086400e037fcaa5da0678573138dd9f2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/hmg/article-pdf/26/15/2864/18757253/ddx167.pdf
PMID 28460056
PQID 1894518278
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1894518278
pubmed_primary_28460056
PublicationCentury 2000
PublicationDate 2017-08-01
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Human molecular genetics
PublicationTitleAlternate Hum Mol Genet
PublicationYear 2017
SSID ssj0016437
Score 2.5590928
Snippet The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF)...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 2864
SubjectTerms Animals
Cell Culture Techniques
Dimethyl Fumarate - chemistry
Dimethyl Fumarate - metabolism
Fibroblasts
Humans
Mice
Mitochondria - metabolism
Multiple Sclerosis - metabolism
Multiple Sclerosis - pathology
Neuroprotective Agents - pharmacology
NF-E2-Related Factor 2 - genetics
NF-E2-Related Factor 2 - metabolism
Organelle Biogenesis
Title Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans
URI https://www.ncbi.nlm.nih.gov/pubmed/28460056
https://www.proquest.com/docview/1894518278
Volume 26
WOSCitedRecordID wos000405706800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qVbz4qK_6IoLXpZuk2U1OImrxYEsPVnor2Tzqgt3WbhX7753sbunFg-BlWQKBZfabmY-ZZD6EblTEjXGEBdJSHrR4DG_SsSDSViaEUqeLYs7rc9ztisFA9qqCW14dq1zGxCJQm4n2NfImEbLFgQzH4nb6EXjVKN9drSQ01lGNAZXxqI4Hqy6Cb0qVt4tCQINgy_GkkjXfxqOmMd-k1Jf_nVoWKaa999-P20e7FbnEdyUaDtCazepoq5SbXNTRdqdqpB-i_kPqtaMX79j5M9ZAOHFxhwSIJ-7OHA2W4rhzPAafhxiZGQ9VnKSTkQ-PaY7TDHste6wygwupv_wI9duPL_dPQaWwEGgWi3mgOU-oAUZgnVAh44oxrSXwbU0h7kWwJiJwchuy2GmluFE-ucEPJUwYIx09RhvZJLOnCBtYCSNjqLS6RYROGOFKkZYTwobEJQ10vTTdEBDs2xIqs5PPfLgyXgOdlPYfTstRG0NInpGfVnr2h93naIf6nFuczrtANQf-ay_Rpv6ap_nsqoAGPLu9zg9J2MTU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dimethyl+fumarate+mediates+Nrf2-dependent+mitochondrial+biogenesis+in+mice+and+humans&rft.jtitle=Human+molecular+genetics&rft.au=Hayashi%2C+Genki&rft.au=Jasoliya%2C+Mittal&rft.au=Sahdeo%2C+Sunil&rft.au=Sacc%C3%A0%2C+Francesco&rft.date=2017-08-01&rft.issn=1460-2083&rft.eissn=1460-2083&rft.volume=26&rft.issue=15&rft.spage=2864&rft_id=info:doi/10.1093%2Fhmg%2Fddx167&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2083&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2083&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2083&client=summon